EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
The Cost of Uncertainty: How Analytical Chemistry Drives Billion-Dollar Decisions in Pharma
In pharmaceutical development uncertainty is not an abstract scientific inconvenience It has a cost a timeline a regulatory consequence and ultimately a patient impact A promising medicine may have strong biological rationale compelling early data and significant commercial potential yet still face a fundamental question do we truly understand the product well enough to develop manufacture approve...
Role of Excipients in Drug Formulation: Functions, Types, and Applications
Whenever we consider medicines we tend to immediately jump into thinking about the active pharmaceutical ingredients APIs the substances that have therapeutic effects However APIs are not enough to develop stable effective and patientfriendly medicines This is where pharmaceutical excipients would come in The importance of excipients in the case of pharmaceuticals can go well beyond the level
Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology
An antibodydrug conjugate is a targeted cancer therapy that links a potent cytotoxic drug to a monoclonal antibody through a chemical linker so the antibody delivers the payload directly to tumour cells expressing a chosen antigen The design widens the therapeutic window it concentrates cytotoxic activity where the target is expressed and limits the systemic exposure that constrains conventional c...
CyberShield Pharma: Assessing Risks in the Digital Age
In todays digital age the pharmaceutical industry faces an increasing number of cyber risks With sensitive patient data intellectual property and critical research at stake companies like CyberShield Pharma
Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics
People respond very differently to medications depending on their weight age inborn capability to metabolize drugs the individual characteristics of the disease or the presence of comorbidities The wellknown assumption that one size fits all has clearly revealed all its limitations and become questionable Notably among humans pediatric patients represent
How Predictive Maintenance Reduces Downtime in Pharma Plants
The pharmaceutical industry is always under stress to enhance the reliability of the production adherence to the regulations and quality of the products without raising the prices and to maintain a continuous supply Machinery malfunctions are not merely a setback in this highstakes game they may compromise batch integrity postpone life and death treatments and put pressure on the market promises
-
Techno Trends
UGA researchers develop oral drug candidate targeting drug-resistant malaria
Researchers from the University of Georgia UGA and the University of Illinois Chicago have developed a new oral antimalarial drug candidate that could help address drugresistant malaria
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Role of Excipients in Drug Formulation: Functions, Types, and Applications
Debi Jones
The excipients of drugs play a crucial role in drug formulations of the modern world, improving stability, bioavailability, and adherence of patients. Much more than dormant additives, they play essen...
-
2
Antibody-Drug Conjugates (ADCs): Driving the Next Generation of Precision Oncology
Lakshmi
Antibody-drug conjugates have moved from salvage therapy to the strategic centre of precision oncology. With more than twenty ADCs approved worldwide and hundreds in development, the decisive question...
-
3
CyberShield Pharma: Assessing Risks in the Digital Age
Kate Williamson
"In the digital age, pharmaceutical companies face escalating cyber risks, including data breaches and ransomware attacks. CyberShield Pharma leads in cybersecurity solutions, safeguarding patien...
-
4
Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics
Guendalina Zuccari
Silvana Alfei
Danilo Marimpietri
Valentina Iurilli
Paola Barabino
Leonardo Marchitto
In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly manipulated and mixed with food by caregivers at h...
-
5
How Predictive Maintenance Reduces Downtime in Pharma Plants
Kate Williamson
The reliability strategies within the pharmaceutical industry are changing with the predictive maintenance pharma practices. Through the application of pharmaceutical predictive analytics, IoT, and AI...
press releases Read more...
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
ANI Pharmaceuticals Inc ANI or the Company Nasdaq ANIP today announced that it received final approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
Wave Life Sciences Ltd Nasdaq WVE a clinicalstage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health today announced the initiation
INFORS HT Launches Multifors 3 bench-top bioreactor for process development
Multifors is what benchscale parallel bioprocessing should look like in Its built around a simple idea the bioreactor should capture and retain the information that matters so scientists can focus
Pretzel Therapeutics Receives FDA Fast Track Designation for PX578 for the Treatment of POLG-mediated Primary Mitochondrial Disorders
Pretzel Therapeutics Inc a clinicalstage biotechnology company advancing a new class of medicines designed to restore mitochondrial function improve cellular energetics and impede disease progression
Events Read more...
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
LATEST NEWS Read more...
Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services
Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands
Variant Bio Expands Target Discovery Collaboration with Boehringer Ingelheim into Cardiovascular Disease
Variant Bio has expanded its multiyear research collaboration and licensing agreement with Boehringer Ingelheim to identify and validate new drug targets for cardiovascular disease
SK pharmteco and GEMMABio strengthen rare disease manufacturing collaboration
SK pharmteco has expanded its collaboration with clinicalstage gene therapy company GEMMABio to support the manufacture of materials for the companys Phase CHARISMA clinical trial for spinal muscular
Envisagenics and Boehringer Ingelheim enter multi-target collaboration for cancer therapi
Envisagenics has entered a multiyear research collaboration and option agreement with Boehringer Ingelheim to investigate tumourspecific targets for potential precision therapies for solid tumours
ExploRNA Therapeutics and Łukasiewicz - IChP partner on GMP manufacturing of mRNA cap analogue
ExploRNA Therapeutics has entered a strategic partnership with the ukasiewicz Research Network Industrial Chemistry Institute ukasiewicz IChP to advance the GMP manufacturing of its mRNA cap analogues
PTC Completes Acquisition of ST-920 Gene Therapy for Fabry Disease
PTC Therapeutics has completed its previously announced agreement with Sangamo Therapeutics to acquire ST isaralgagene civaparvovec a onetime AAV gene therapy candidate being developed for Fabry disease








